Tumor necrosis factor α is a risk factor for infection in peritoneal dialysis patients

Korean J Intern Med. 2016 Jul;31(4):722-9. doi: 10.3904/kjim.2015.230. Epub 2016 Mar 22.

Abstract

Background/aims: It has been shown that circulating tumor necrosis factor α (TNF-α) is elevated in end stage renal disease patients; however, the relationship between TNF-α and the development of infection in these patients is unknown. In this study, we investigated the association of plasma TNF-α and interleukin 6 (IL-6) with infection in peritoneal dialysis (PD) patients. We also evaluated the association of their plasma levels with the production by peripheral blood mononuclear cells (PBMC), and with various clinical parameters.

Methods: We enrolled 32 patients on maintenance PD and 10 healthy controls. Plasma and PBMC were isolated from blood. PBMC were stimulated with lipopolysaccharide in vitro.

Results: Mean follow-up duration was 775 days. Six patients developed organ infections (five pneumonia and one liver abscess), and six patients developed PD peritonitis and eight developed exit site infection. Plasma TNF-α and IL-6 levels were significantly elevated in organ infections but not in peritonitis or in exit site infection. Plasma TNF-α was the only significant risk factor for organ infections and pneumonia in multivariate regression analysis. Patients with high plasma TNF-α levels showed a significantly greater cumulative hazard rate for organ infections compared to those with low TNF-α levels. Plasma TNF-α levels correlated with TNF-α production by PBMC and showed an inverse association with Kt/V.

Conclusions: This is the first study showing that plasma TNF-α is a significant risk factor for infection in PD patients.

Keywords: Infection; Interleukin-6; Peripheral blood mononuclear cell; Peritoneal dialysis; Tumor necrosis factor-alpha.

MeSH terms

  • Case-Control Studies
  • Cells, Cultured
  • Communicable Diseases / blood
  • Communicable Diseases / etiology*
  • Communicable Diseases / immunology
  • Female
  • Humans
  • Interleukin-6 / blood
  • Kidney Failure, Chronic / blood
  • Kidney Failure, Chronic / diagnosis
  • Kidney Failure, Chronic / therapy*
  • Leukocytes, Mononuclear / drug effects
  • Leukocytes, Mononuclear / immunology
  • Leukocytes, Mononuclear / metabolism*
  • Lipopolysaccharides / pharmacology
  • Male
  • Peritoneal Dialysis / adverse effects*
  • Risk Factors
  • Time Factors
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / blood
  • Tumor Necrosis Factor-alpha / immunology
  • Tumor Necrosis Factor-alpha / metabolism*
  • Up-Regulation

Substances

  • IL6 protein, human
  • Interleukin-6
  • Lipopolysaccharides
  • Tumor Necrosis Factor-alpha